Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

PURPOSE: Specific activating mutations within the epidermal growth factor receptor (EGFR) identify a subset of non – small cell lung cancers with dramatic sensitivity to the specific tyrosine kinase inhibitors (TKI), gefitinib and erlotinib. Despite the abundant expression of EGFR protein in a broad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kwak, Eunice L., Jankowski, Janusz, Thayer, Sarah P., Lauwers, Gregory Y., Brannigan, Brian W., Harris, Patricia L., Okimoto, Ross A., Haserlat, Sara M., Dris coll, David R., Ferry, David, Muir, Beth, Settleman, Jeff, Fuchs, Charles S., Kulke, Matthew H., Ryan, David P., Clark, Jeff W., Sgroi, Dennis C., Haber, Daniel A., Bell, Daphne W.
Format: Artigo
Idioma:Inglês
Publicat: 2006
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3807136/
https://ncbi.nlm.nih.gov/pubmed/16857803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-06-0189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars